IVHD-valtrate

IVHD-valtrate, an active Valeriana jatamansi derivative, is against human ovarian cancer cells in vitro and in vivo. IVHD-valtrate induces cancer cells apoptosis and arrests the ovarian cancer cells in the G2/M phase. IVHD-valtrate has the potential to be a novel chemotherapeutic agent for the human ovarian cancer research[1].

Product Specifications

CAS Number

[28325-56-6]

UNSPSC

12352005

Target

Apoptosis

Type

Natural Products

Related Pathways

Apoptosis

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ivhd-valtrate.html

Solubility

10 mM in DMSO

Smiles

CC(O[C@@H](C1)[C@]2(CO2)[C@]([C@@H]3OC(CC(C)C)=O)([H])[C@]1(C(COC(C(C(C)C)OC(CC(C)C)=O)=O)=CO3)O)=O

Molecular Formula

C27H40O11

Molecular Weight

540.60

References & Citations

[1]Xiaoguang Li, et al. Valeriana jatamansi constituent IVHD-valtrate as a novel therapeutic agent to human ovarian cancer: in vitro and in vivo activities and mechanisms. Curr Cancer Drug Targets. 2013 May;13 (4) :472-83.